Little SF - Search Results

1

Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.

Vitale L, Blanset D, Lowy I, O'Neill T, Goldstein J, Little SF, Andrews GP, Dorough G, Taylor RK, Keler T. Vitale L, et al. Among authors: little sf. Infect Immun. 2006 Oct;74(10):5840-7. doi: 10.1128/IAI.00712-06. Infect Immun. 2006. PMID: 16988263 Free PMC article.

2

Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.

Little SF, Ivins BE, Webster WM, Fellows PF, Pitt ML, Norris SL, Andrews GP. Little SF, et al. Vaccine. 2006 Mar 24;24(14):2530-6. doi: 10.1016/j.vaccine.2005.12.028. Epub 2005 Dec 27. Vaccine. 2006. PMID: 16417950

3

Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages.

Mohamed N, Li J, Ferreira CS, Little SF, Friedlander AM, Spitalny GL, Casey LS. Mohamed N, et al. Among authors: little sf. Infect Immun. 2004 Jun;72(6):3276-83. doi: 10.1128/IAI.72.6.3276-3283.2004. Infect Immun. 2004. PMID: 15155630 Free PMC article.

4

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.

Little SF, Ivins BE, Fellows PF, Pitt ML, Norris SL, Andrews GP. Little SF, et al. Vaccine. 2004 Jan 2;22(3-4):422-30. doi: 10.1016/j.vaccine.2003.07.004. Vaccine. 2004. PMID: 14670324

5

Development of an in vitro-based potency assay for anthrax vaccine.

Little SF, Webster WM, Ivins BE, Fellows PF, Norris SL, Andrews GP. Little SF, et al. Vaccine. 2004 Jul 29;22(21-22):2843-52. doi: 10.1016/j.vaccine.2003.12.027. Vaccine. 2004. PMID: 15246620

6

Evaluation of an anti-rPA IgG ELISA for measuring the antibody response in mice.

Little SF, Webster WM, Norris SL, Andrews GP. Little SF, et al. Biologicals. 2004 Jun;32(2):62-9. doi: 10.1016/j.biologicals.2004.02.001. Biologicals. 2004. PMID: 15454183

7

Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.

Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP. Ribot WJ, et al. Among authors: little sf. Vaccine. 2006 Apr 24;24(17):3469-76. doi: 10.1016/j.vaccine.2006.02.013. Epub 2006 Feb 21. Vaccine. 2006. PMID: 16519970

8

Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine.

Little SF, Ivins BE, Webster WM, Norris SL, Andrews GP. Little SF, et al. Vaccine. 2007 Apr 12;25(15):2771-7. doi: 10.1016/j.vaccine.2006.12.043. Epub 2007 Jan 2. Vaccine. 2007. PMID: 17240008

9

Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.

Little SF, Knudson GB. Little SF, et al. Infect Immun. 1986 May;52(2):509-12. doi: 10.1128/iai.52.2.509-512.1986. Infect Immun. 1986. PMID: 3084385 Free PMC article.

10

Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants.

Ivins BE, Welkos SL, Little SF, Crumrine MH, Nelson GO. Ivins BE, et al. Among authors: little sf. Infect Immun. 1992 Feb;60(2):662-8. doi: 10.1128/iai.60.2.662-668.1992. Infect Immun. 1992. PMID: 1730501 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters